首页> 美国卫生研究院文献>World Journal of Hepatology >Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence diagnosis and clinical significance
【2h】

Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence diagnosis and clinical significance

机译:人类免疫缺陷病毒阳性患者的隐匿性乙型肝炎病毒共感染:流行诊断和临床意义的审查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The prevalence of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection is high as they share similar mechanisms of transmission. The development and widespread use of highly sensitive tests for HBV diagnosis has demonstrated that a significant proportion of apparently healthy individuals with evidence of exposure to HBV continue to carry fully functional HBV DNA in their hepatocytes, a situation that predisposes them to the development of progressive liver disease and hepatocellular carcinoma. The presence of co-infections frequently influences the natural evolution of each of the participating infections present by either facilitating their virulence or competing for resources. Furthermore, the drugs used to treat these infections may also contribute to changes in the natural course of these infections, making the analysis of the impact of co-infection more difficult. The majority of studies has examined the impact of HIV on overt chronic hepatitis B, finding that co-infection carries an increased risk of progressive liver disease and the development of hepatocellular carcinoma. Although the effect of HIV on the natural history of occult hepatitis B infection (OBI) has not been fully assessed, all available data suggest a persisting risk of repeated flares of hepatitis and progressive liver disease. We describe studies regarding the diagnosis, prevalence and clinical significance of OBI in HIV-positive patients in this short review. Discrepancies in worldwide prevalence show the urgent need for the standardization of diagnostic criteria, as established by the Taormina statements. Ideally, standardized protocols for testing should be employed to enable the comparison of data from different groups. Additional studies are needed to define the differences in risk for OBI without HIV and in HIV-HBV co-infected patients with or without overt disease.
机译:人类免疫缺陷病毒(HIV)和乙型肝炎病毒(HBV)共同感染的患病率很高,因为它们具有相似的传播机制。高敏感度检测技术的发展和广泛使用证明,HBV暴露的明显健康个体中,相当一部分健康的个体继续在其肝细胞中携带功能全面的HBV DNA,这使他们容易发展为进行性肝病疾病和肝细胞癌。合并感染的存在常常通过促进其毒力或争夺资源来影响存在的每种参与感染的自然进化。此外,用于治疗这些感染的药物也可能会导致这些感染自然过程的变化,从而使得对共感染影响的分析更加困难。大多数研究检查了HIV对明显的慢性乙型肝炎的影响,发现共同感染会增加进行性肝病和肝细胞癌发展的风险。尽管尚未完全评估HIV对隐匿性乙型肝炎感染(OBI)的自然史的影响,但所有现有数据表明,反复发作肝炎和进行性肝病的风险仍然存在。在这篇简短的评论中,我们描述了有关HIV阳性患者OBI的诊断,患病率和临床意义的研究。正如陶尔米纳声明所表明的那样,全球患病率差异表明迫切需要诊断标准的标准化。理想情况下,应采用标准化的测试协议来比较不同组的数据。需要进一步的研究来确定没有HIV的OBI风险和有或没有显性疾病的HIV-HBV合并感染患者的风险差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号